Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

ジュネーブ--(BUSINESS WIRE)--（ビジネスワイヤ） -- オーラルBは、世界中の歯科医が使用し、推奨するナンバーワンの歯ブラシ・ブランドであり、オーラルB iOテクノロジーの優位性をさらに裏付ける新たなエビデンスを発表しました。19件のランダム化臨床研究（参加者1,300人超）を対象とする2026年の独立した査読済みネットワーク・メタアナリシスで、オーラルB iOに採用されているオシレーション・ロータリー技術は、歯垢除去と歯肉炎の軽減で第1位に評価されました。 多くの人は効果的に歯を磨けていると思っていますが、実際に正しく磨くのはそう簡単ではありません。歯垢は、歯肉縁、歯間、奥歯の周囲など、磨きにくい箇所に残りがちです。実際、80%の人が歯磨きの際に少なくとも1か所を磨き残し、60%は奥歯を磨き残しています。こうした歯垢の蓄積は、時間の経過とともに口腔の健康やウェルビーイングに影響を及ぼす可能性があります。 「人々は毎日歯を磨いていますが、特に重要な部位を効果的に磨くことは、必ずしも容易ではありません」と、オーラルヘルス・サイエンス＆プロフェッショナル・サイエンティフ...

日內瓦--(BUSINESS WIRE)--(美國商業資訊)-- 全球牙醫使用和推薦最多的牙刷品牌Oral-B今日公布全新證據，進一步印證Oral-B iO技術的優越性。2026年一項獨立的同儕審查網絡統合分析涵蓋19項隨機臨床研究，受試者超過1300人。分析結果顯示，Oral-B iO搭載的旋轉擺動技術在去除牙菌斑和減輕牙齦炎兩項指標上名列第一。 大多數人自認為刷牙方式有效，但好好刷牙其實比看上去更難。牙菌斑常常殘留在最難潔淨的位置，包括牙齦邊緣、牙縫以及大臼齒周邊。事實上，80%的人刷牙時至少會漏掉一處區域，60%的人會忽略大臼齒。久而久之，堆積的牙菌斑會影響口腔健康與身體狀態。 口腔健康科學與專業科研關係資深總監Svetlana Farrell, DDS博士表示：「人們每天都會刷牙，但要在關鍵部位始終實現有效潔淨並非易事。Oral-B iO的設計以一個簡單事實為基礎：好好刷牙遠比大多數人想像的更難。它能夠導引人們更徹底地刷牙、控制合適力度，讓出色的潔淨效果更容易實現。」 證據確鑿：Oral-B iO潔淨效果更佳 2026年一項獨立的同儕審查網絡統合分析涵蓋19項隨機臨床研究，受試...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

日内瓦--(BUSINESS WIRE)--(美国商业资讯)-- 全球牙医使用和推荐最多的牙刷品牌Oral-B今日公布全新证据，进一步印证Oral-B iO技术的优越性。2026年一项独立的同行评审网状荟萃分析汇总19项随机临床研究，受试者超过1300人。分析结果显示，Oral-B iO搭载的旋转摆动技术在清除牙菌斑和减轻牙龈炎两项指标上位列第一。 大多数人自认为刷牙方式有效，但好好刷牙其实比看上去更难。牙菌斑常常残留在最难清洁的位置，包括牙龈边缘、牙缝以及磨牙周边。事实上，80%的人刷牙时至少会漏掉一处区域，60%的人会忽略磨牙。久而久之，堆积的牙菌斑会影响口腔健康与身体状态。 口腔健康科学与专业科研关系高级总监Svetlana Farrell, DDS博士表示：“人们每天都会刷牙，但要在关键部位始终实现有效清洁并非易事。Oral-B iO的设计基于一个简单事实：好好刷牙远比大多数人想象的更难。它能够引导人们更彻底地刷牙、控制合适力度，让出色的清洁效果更容易实现。” 证据确凿：Oral-B iO清洁效果更佳 2026年一项独立的同行评审网状荟萃分析汇总19项随机临床研究，受试者超过1...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

GENEBRA--(BUSINESS WIRE)--Oral-B, marca de escovas de dentes nº 1 usada e recomendada por dentistas em todo o mundo, anunciou hoje novas evidências que reforçam a superioridade da tecnologia Oral-B iO. Em uma meta-análise de rede independente, revisada por pares e publicada em 2026, que abrangeu 19 estudos clínicos randomizados com mais de 1.300 participantes, a tecnologia oscilatória-rotatória da Oral-B iO foi classificada em primeiro lugar na remoção de placa bacteriana e na redução da gengiv...

GINEVRA--(BUSINESS WIRE)--Oral-B, il 1º marchio di spazzolini utilizzato e consigliato dai dentisti di tutto il mondo, ha annunciato oggi la pubblicazione di nuove prove che ribadiscono la superiorità della tecnologia Oral-B iO. In una meta-analisi di rete indipendente condotta nel 2026 e sottoposta a revisione tra pari di 19 studi clinici randomizzati che ha coinvolto più di 1.300 partecipanti, la tecnologia di roto-oscillazione alla base di Oral-B iO si è classificata al 1º posto per la rimoz...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave, Inc. (Nasdaq: CRWV) (“CoreWeave”) today announced its intention to offer, subject to market and other conditions, $3.0 billion aggregate principal amount of its convertible senior notes due 2033 (the “Notes”) in a private offering. CoreWeave also intends to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an addition...